Benitez, Pacita M.
HRN: 26-96-38 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/16/2025
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
04/16/2025
04/23/2025
IV
500mg
Q6
Psoas Abscess
Waiting Final Action
Indication: Empiric Type of Infection: Bone & JointSkin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes